(CVX) Chevron - Overview
Stock: Crude Oil, Natural Gas, Petroleum Products, Lubricants, Petrochemicals
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.56% |
| Yield on Cost 5y | 11.65% |
| Yield CAGR 5y | 6.53% |
| Payout Consistency | 84.2% |
| Payout Ratio | 94.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.5% |
| Relative Tail Risk | -0.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.84 |
| Alpha | 12.07 |
| Character TTM | |
|---|---|
| Beta | 0.652 |
| Beta Downside | 1.116 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.64% |
| CAGR/Max DD | 0.30 |
Description: CVX Chevron January 28, 2026
Chemical and energy giant Chevron Corp (NYSE: CVX) operates an integrated business split between Upstream (exploration, production, LNG, and carbon-capture activities) and Downstream (refining, marketing, renewable fuels, petrochemicals, and logistics). The company, founded in 1879 and headquartered in Houston, Texas, was renamed from ChevronTexaco in 2005.
In its most recent quarterly filing (Q4 2025), Chevron reported upstream production of 3.1 million barrels of oil equivalent per day (≈ 5 % YoY growth driven by new offshore assets), downstream refining margins of $13 per barrel, and free cash flow of $30 billion, supporting a dividend yield of ~4.5 % and a share-repurchase program of $5 billion. Capital expenditures were $12 billion, with $4 billion earmarked for LNG projects and $2 billion for carbon-capture initiatives.
Key sector drivers include sustained global demand for LNG (projected 7 % CAGR through 2030), tightening emissions regulations prompting higher investment in renewable fuels and CCS, and oil price volatility linked to OPEC+ output policies and macro-economic growth differentials. These factors together shape Chevron’s cash-flow sensitivity and long-term growth outlook.
For a deeper quantitative assessment, the ValueRay platform provides a granular breakdown of CVX’s cash-flow sensitivity to oil-price scenarios.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 12.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.96 > 1.0 |
| NWC/Revenue: -0.00% < 20% (prev 1.22%; Δ -1.22% < -1%) |
| CFO/TA 0.10 > 3% & CFO 33.75b > Net Income 12.31b |
| Net Debt (34.47b) to EBITDA (41.09b): 0.84 < 3 |
| Current Ratio: 1.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.00b) vs 12m ago 12.36% < -2% |
| Gross Margin: 14.74% > 18% (prev 0.29%; Δ 1445 % > 0.5%) |
| Asset Turnover: 64.01% > 50% (prev 75.28%; Δ -11.26% > 0%) |
| Interest Coverage Ratio: 17.22 > 6 (EBITDA TTM 41.09b / Interest Expense TTM 1.22b) |
Altman Z'' 3.98
| A: -0.00 (Total Current Assets 40.75b - Total Current Liabilities 40.76b) / Total Assets 324.01b |
| B: 0.64 (Retained Earnings 206.01b / Total Assets 324.01b) |
| C: 0.07 (EBIT TTM 20.96b / Avg Total Assets 290.48b) |
| D: 1.36 (Book Value of Equity 186.45b / Total Liabilities 137.56b) |
| Altman-Z'' Score: 3.98 = AA |
What is the price of CVX shares?
Over the past week, the price has changed by +2.24%, over one month by +15.54%, over three months by +19.58% and over the past year by +24.58%.
Is CVX a buy, sell or hold?
- StrongBuy: 9
- Buy: 6
- Hold: 9
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the CVX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 181.7 | 0.4% |
| Analysts Target Price | 181.7 | 0.4% |
| ValueRay Target Price | 200.2 | 10.7% |
CVX Fundamental Data Overview February 07, 2026
P/E Forward = 23.31
P/S = 1.9438
P/B = 1.9033
P/EG = 3.5288
Revenue TTM = 185.94b USD
EBIT TTM = 20.96b USD
EBITDA TTM = 41.09b USD
Long Term Debt = 37.95b USD (from longTermDebt, two quarters ago)
Short Term Debt = 3.59b USD (from shortTermDebt, two quarters ago)
Debt = 40.76b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 34.47b USD (from netDebt column, last quarter)
Enterprise Value = 361.61b USD (361.60b + Debt 40.76b - CCE 40.75b)
Interest Coverage Ratio = 17.22 (Ebit TTM 20.96b / Interest Expense TTM 1.22b)
EV/FCF = 22.35x (Enterprise Value 361.61b / FCF TTM 16.18b)
FCF Yield = 4.48% (FCF TTM 16.18b / Enterprise Value 361.61b)
FCF Margin = 8.70% (FCF TTM 16.18b / Revenue TTM 185.94b)
Net Margin = 6.62% (Net Income TTM 12.31b / Revenue TTM 185.94b)
Gross Margin = 14.74% ((Revenue TTM 185.94b - Cost of Revenue TTM 158.53b) / Revenue TTM)
Gross Margin QoQ = 11.36% (prev 11.57%)
Tobins Q-Ratio = 1.12 (Enterprise Value 361.61b / Total Assets 324.01b)
Interest Expense / Debt = 0.89% (Interest Expense 361.0m / Debt 40.76b)
Taxrate = 38.14% (1.75b / 4.60b)
NOPAT = 12.97b (EBIT 20.96b * (1 - 38.14%))
Current Ratio = 1.00 (Total Current Assets 40.75b / Total Current Liabilities 40.76b)
Debt / Equity = 0.22 (Debt 40.76b / totalStockholderEquity, last quarter 186.45b)
Debt / EBITDA = 0.84 (Net Debt 34.47b / EBITDA 41.09b)
Debt / FCF = 2.13 (Net Debt 34.47b / FCF TTM 16.18b)
Total Stockholder Equity = 167.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.24% (Net Income 12.31b / Total Assets 324.01b)
RoE = 7.33% (Net Income TTM 12.31b / Total Stockholder Equity 167.99b)
RoCE = 10.18% (EBIT 20.96b / Capital Employed (Equity 167.99b + L.T.Debt 37.95b))
RoIC = 6.64% (NOPAT 12.97b / Invested Capital 195.40b)
WACC = 7.53% (E(361.60b)/V(402.36b) * Re(8.32%) + D(40.76b)/V(402.36b) * Rd(0.89%) * (1-Tc(0.38)))
Discount Rate = 8.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 3.39%
[DCF Debug] Terminal Value 76.80% ; FCFF base≈15.83b ; Y1≈13.01b ; Y5≈9.30b
Fair Price DCF = 77.05 (EV 187.02b - Net Debt 34.47b = Equity 152.55b / Shares 1.98b; r=7.53% [WACC]; 5y FCF grow -21.46% → 2.90% )
EPS Correlation: -92.50 | EPS CAGR: -19.07% | SUE: 0.39 | # QB: 0
Revenue Correlation: -72.75 | Revenue CAGR: -3.49% | SUE: 0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.48 | Chg30d=-0.292 | Revisions Net=-2 | Analysts=18
EPS current Year (2026-12-31): EPS=6.86 | Chg30d=-0.543 | Revisions Net=-9 | Growth EPS=-5.9% | Growth Revenue=-2.5%
EPS next Year (2027-12-31): EPS=9.13 | Chg30d=-0.609 | Revisions Net=-9 | Growth EPS=+33.1% | Growth Revenue=+4.6%